Moderna Inc. said Tuesday that its modified COVID-19 booster vaccine candidate provides better protection against omicron and a number of virus variants than its currently available coronavirus vaccine.
The data has not yet been vetted by independent experts.
Before the global emergence of omicron, Moderna was studying a combination shot that added protection against the beta variant. A health worker administers a dose of a Moderna COVID-19 vaccine during a vaccination clinic at the Norristown Public Health Center in Norristown, Pa., Tuesday, Dec. 7, 2021.
"We are pleased with these data for our first bivalent booster candidate, mRNA-1273.211. We believe that these results validate our bivalent strategy, which we announced and began pursuing in February 2021," Moderna CEO Stéphane Bancel said in a statement. "Our latest bivalent booster candidate, mRNA-1273.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Gap Inc. Gets Upgraded But Needs ‘Significant Transformation’The Morgan Stanley upgrade follows a string of Gap Inc. downgrades by other financial institutions this year.
Les mer »
Moderna says redesigned Covid booster provides better protectionThe drugmaker said its 'bivalent' vaccine generated a strong immune response against multiple variants of concern, including omicron.
Les mer »
Moderna hopes to offer updated COVID-19 booster for latest variant this fallModerna hopes to offer updated COVID-19 boosters in the fall that combine the original vaccine with protection against the latest variant.
Les mer »
Moderna announces step toward updating COVID shots shots for fallModerna hopes to offer updated COVID-19 boosters in the fall that combine its original vaccine with protection against the omicron variant. On Tuesday, it reported a preliminary hint that such an approach might work.
Les mer »
Moderna announces step toward updating COVID shots for fallModerna hopes to offer updated COVID-19 boosters in the fall that combine its original vaccine with protection against the omicron variant. Before omicron came along, Moderna was studying a combination shot that added protection against an earlier variant named beta. Tuesday, the company said people given that beta-original vaccine combination produced more antibodies capable of fighting several variants — including omicron — than today’s regular booster triggers.
Les mer »
Moderna will likely update COVID-19 booster with protection against omicronThe company says people who were administered that test combo shot developed more antibodies capable of fighting newer variants — including omicron — than today's regular booster.
Les mer »